Jun Nakashima
-
- Prostate Cancer Diagnosis and Treatment 49
- Prostate Cancer Treatment and Research 43
- Renal cell carcinoma treatment 14
- Urology top 1%
- Urological Disorders and Treatments 13
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 14
- Oncology top 2%
- Rheumatology top 2%
- Urologic and reproductive health conditions 21
-
- Bladder and Urothelial Cancer Treatments 23
- Urinary and Genital Oncology Studies 15
Jun Nakashima
169 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 139
- Pulmonary and Respiratory Medicine 1.7k
- Urology 296
- Cancer Research 638
- Oncology 1.1k
- Rheumatology 416
Countries citing papers authored by Jun Nakashima
This map shows the geographic impact of Jun Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Nakashima more than expected).
Fields of papers citing papers by Jun Nakashima
This network shows the impact of papers produced by Jun Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Nakashima. The network helps show where Jun Nakashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 13 | |
| 2 | 2014 | 5 | |
| 3 | 2013 | 26 | |
| 4 | 2012 | 2 | |
| 5 | 2012 | 33 | |
| 6 | 2011 | 8 | |
| 7 | 2009 | 3 | |
| 8 | 2009 | 24 | |
| 9 | 2008 | 43 | |
| 10 | 2008 | 22 | |
| 11 | 2008 | 16 | |
| 12 | 2006 | 272 | |
| 13 | Prostate MR imaging for patients with elevated serum PSA levels. The clinical value of diffusion-weighted and dynamic MR imaging in cancer screening | 2006 | 1 |
| 14 | 2003 | 36 | |
| 15 | 2001 | 5 | |
| 16 | 2000 | 2 | |
| 17 | 2000 | 8 | |
| 18 | The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer. | 1997 | 13 |
| 19 | 1997 | 45 | |
| 20 | 1995 | 4 |
About Jun Nakashima
Jun Nakashima is a scholar working on Urology, Pulmonary and Respiratory Medicine, Cancer Research, Rheumatology and Oncology, having authored 173 papers that have together received 4.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (49 papers), Prostate Cancer Treatment and Research (43 papers), Bladder and Urothelial Cancer Treatments (23 papers), Urologic and reproductive health conditions (21 papers), Urinary and Genital Oncology Studies (15 papers), Renal cell carcinoma treatment (14 papers), Cancer, Lipids, and Metabolism (14 papers) and Urological Disorders and Treatments (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Urology (296 citations), Cancer Research (638 citations), Oncology (1.1k citations) and Rheumatology (416 citations). Jun Nakashima has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masaru Murai, Masaaki Tachibana, Takashi Ohigashi, Yoshio Ohno, Makoto Ohori, Mototsugu Oya, Yutaka Horiguchi, Akira Miyajima, Tadashi Hatano and Ken Marumo. Their work appears in journals such as The Journal of Urology, International Journal of Urology, Urology, International Journal of Clinical Oncology and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.